arrow
Back
I

Irene L. M. Reijers

Royal Marsden NHS Foundation Trust

17H-index
137Paper Count
2.0KCitation Count
Published Papers 28
Publication Date
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
err2025-11-01
err0
errOAAI
errRohrberg, Kristoffer Staal; Lopez, Juanita S.; Milhem, Mohammed M.; Blank, Christian U.; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A.; Janne, Pasi A.; Shum, Elaine; Shaw, Heather M.; Debruyne, Philip R.; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H.; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schoffski, Patrick; Chen, Andrew William; Cohen, Eric A.; Mankowski, Walter C.; Roshkovan, Leonid; Katz, Sharyn I.; Kontos, Despina; Brady, Lauren K.; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W.; Amiri, Katayoun I.; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S.; Vergote, Ignace
errShare
errSave
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma
err2025-09-30
err0
errOAAI
errJudith M. Versluis; Huma Shehwana; Robert Elens; Alexander M. Menzies; Irene L. M. Reijers; Petros Dimitriadis; Nigel G. Maher; Astrid M. M. van der Veldt; Ellen Kapiteijn; Annegien Broeks; Richard A. Scolyer; Bart A. van de Wiel; Alexander C. J. van Akkooi; Ton N. Schumacher; Georgina V. Long; Christian U. Blank
errShare
errSave
Targeted Therapy for Rare BRAF-Mutated Melanoma: Updated Multicenter Analysis and Launch of a Publicly Accessible Online Outcome Database
err2025-08-09
err0
PREAI
errChristian Menzer; Susanne Dugas-Breit; Martin Dugas; Christian U. Blank; Emma J. Groen; Irene Reijers; Max Schlaak; Julia Eckardt; Karijn P.M. Suijkerbuijk; Lisa Zimmer; Douglas B. Johnson; Cindy Franklin; Frank Meiss; Bastian Schilling; Friedegund Meier; Ralf Gutzmer; Kai-Martin Thoms; Thomas Haalck; Marilena Müller; Annette Kopp-Schneider; Matteo S. Carlino; Georgina V. Long; Alexander M. Menzies; Astrid A.M. van der Veldt; Jan Willem B. de Groot; Thomas Eigentler; Marion Stevense-den Boer; Claudia Pföhler; Karin Herbschleb; Jessica C. Hassel
errShare
errSave
High concurrent interferon gamma signature expression in the primary tumor and lymph node metastasis is associated with superior outcome upon neoadjuvant ipilimumab plus nivolumab in stage III melanoma
err2024-09-01
err0
PREAI
errHoeijmakers, L.; Dimitriadis, P.; Cornelissen, S.; Reijers, I.; van de Wiel, B.; Scolyer, R. A.; Saw, R. P. M.; Spillane, A. J.; Broeks, A.; Lopez-Yurda, M.; Grijpink-Ongering, L.; Hospers, G.; Menzies, A. M.; van Akkooi, A. C. J.; Van Houdt, W.; Long, G. V.; Blank, C. U.
errShare
errSave
Altered microbial community stability and increases in circulating B cells are associated with the development of severe immune related adverse events during ICI-immunotherapy
err2024-03-22
err0
PREAI
errSimpson, Rebecca C.; Shanahan, Erin R.; Silva, Ines P.; Reijers, Irene L.; Versluis, Judith M.; Menzies, Alexander M.; Maria, Gonzalez; Palendira, Umaimainthan; Wilmott, James S.; Blank, Christian; Scolyer, Richard A.; Long, Georgina V.
errShare
errSave
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma
err2023-11-13
err12
PREAI
errFraterman, Itske; Reijers, Irene L. M.; Dimitriadis, Petros; Broeks, Annegien; Gonzalez, M.; Menzies, A. M. M.; Lopez-Yurda, Marta; Kapiteijn, Ellen; van der Veldt, Astrid A. M.; Suijkerbuijk, Karijn P. M.; Hospers, Geke A. P.; Long, Georgina V.; Blank, Christian U.; van de Poll-franse, Lonneke V.
errShare
errSave
Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
err2023-10-01
err1
errOAAI
errReijers, I.; Dimitriadis, P.; Menzies, A. M.; Kapiteijn, E.; Van der Veldt, A. A. M.; Suijkerbuijk, K. P. M.; Hospers, G. A. P.; Van Houdt, W.; Saw, R.; Broeks, A.; Cornelissen, S.; Grijpink-Ongering, L.; Pennington, T.; Colebatch, A.; de Wiel, B. van; Scolyer, R.; van Akkooi, A. C. J.; Long, G. V.; Blank, C. U.
errShare
errSave
Longitudinal microbiome-immune dynamics in melanoma patients treated with immune checkpoint inhibitor immunotherapy
err2023-04-04
err0
PREAI
errSimpson, Rebecca C.; Shanahan, Erin R.; Batten, Marcel; Silva, Ines P.; Reijers, Irene L.; Versluis, Judith M.; Menzies, Alexander M.; Gonzalez, Maria; Palendira, Umaimainthan; Holmes, Andrew; Wilmott, James S.; Blank, Christian U.; Scolyer, Richard A.; Long, Georgina V.
errShare
errSave
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
err2023-03-15
err32
errOAAI
errReijers, Irene L. M.; Rao, Disha; Versluis, Judith M.; Menzies, Alexander M.; Dimitriadis, Petros; Wouters, Michel W.; Spillane, Andrew J.; Klop, Willem M. C.; Broeks, Annegien; Bosch, Linda J. W.; Lopez-Yurda, Marta; van Houdt, Winan J.; Rawson, Robert V.; Grijpink-Ongering, Lindsay G.; Gonzalez, Maria; Cornelissen, Sten; Bouwman, Jasper; Sanders, Joyce; Plasmeijer, Elsemieke; Elshot, Yannick S.; Scolyer, Richard A.; van de Wiel, Bart A.; Peeper, Daniel S.; van Akkooi, Alexander C. J.; Long, Georgina V.; Blank, Christian U.
errShare
errSave
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
err2022-09-22
err97
PREAI
errSimpson, Rebecca C.; Shanahan, Erin R.; Batten, Marcel; Reijers, Irene L. M.; Read, Mark; Silva, Ines P.; Versluis, Judith M.; Ribeiro, Rosilene; Angelatos, Alexandra S.; Tan, Jian; Adhikari, Chandra; Menzies, Alexander M.; Saw, Robyn P. M.; Gonzalez, Maria; Shannon, Kerwin F.; Spillane, Andrew J.; Velickovic, Rebecca; Lazar, Alexander J.; Damania, Ashish, V; Mishra, Aditya K.; Chelvanambi, Manoj; Banerjee, Anik; Ajami, Nadim J.; Wargo, Jennifer A.; Macia, Laurence; Holmes, Andrew J.; Wilmott, James S.; Blank, Christian U.; Scolyer, Richard A.; Long, Georgina, V
errShare
errSave
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
err2022-09-01
err29
errOAAI
errDimitriou, F.; Namikawa, K.; Reijers, I. L. M.; Buchbinder, E., I; Soon, J. A.; Zaremba, A.; Teterycz, P.; Mooradian, M. J.; Armstrong, E.; Nakamura, Y.; Vitale, M. G.; Tran, L. E.; Bai, X.; Allayous, C.; Provent-Roy, S.; Indini, A.; Bhave, P.; Farid, M.; Kahler, K. C.; Mehmi, I; Atkinson, V; Klein, O.; Stonesifer, C. J.; Zaman, F.; Haydon, A.; Carvajal, R. D.; Hamid, O.; Dummer, R.; Hauschild, A.; Carlino, M. S.; Mandala, M.; Robert, C.; Lebbe, C.; Guo, J.; Johnson, D. B.; Ascierto, P. A.; Shoushtari, A. N.; Sullivan, R. J.; Cybulska-Stopa, B.; Rutkowski, P.; Zimmer, L.; Sandhu, S.; Blank, C. U.; Lo, S. N.; Menzies, A. M.; Long, G., V
errShare
errSave
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
err2022-07-12
err7
errOAAI
errFessenden, Tim B.; Stopfer, Lauren E.; Chatterjee, Fiona; Zulueta, Julian; Mesfin, Josh; Cordero Dumit, Therese; Reijers, Irene; Hoefsmit, Esmee P.; Blank, Christian; White, Forest; Spranger, Stefani
errShare
errSave
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
err2022-06-05
err170
errOAAI
errReijers, Irene L. M.; Menzies, Alexander M.; van Akkooi, Alexander C. J.; Versluis, Judith M.; van den Heuvel, Noelle M. J.; Saw, Robyn P. M.; Pennington, Thomas E.; Kapiteijn, Ellen; van der Veldt, Astrid A. M.; Suijkerbuijk, Karijn P. M.; Hospers, Geke A. P.; Rozeman, Elisa A.; Klop, Willem M. C.; van Houdt, Winan J.; Sikorska, Karolina; van der Hage, Jos A.; Grunhagen, Dirk J.; Wouters, Michel W.; Witkamp, Arjen J.; Zuur, Charlotte L.; Lijnsvelt, Judith M.; Torres Acosta, Alejandro; Grijpink-Ongering, Lindsay G.; Gonzalez, Maria; Jozwiak, Katarzyna; Bierman, Carolien; Shannon, Kerwin F.; Ch'ng, Sydney; Colebatch, Andrew J.; Spillane, Andrew J.; Haanen, John B. A. G.; Rawson, Robert V.; van de Wiel, Bart A.; van de Poll-franse, Lonneke V.; Scolyer, Richard A.; Boekhout, Annelies H.; Long, Georgina V.; Blank, Christian U.
errShare
errSave
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors
err2022-04-27
err27
errOAAI
errKaptein, Paulien; Jacoberger-Foissac, Celia; Dimitriadis, Petros; Voabil, Paula; de Bruijn, Marjolein; Brokamp, Simone; Reijers, Irene; Versluis, Judith; Nallan, Gahyathiri; Triscott, Hannah; McDonald, Elizabeth; Tay, Joshua; Long, Georgina, V; Blank, Christian U.; Thommen, Daniela S.; Teng, Michele W. L.
errShare
errSave
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
err2022-04-01
err22
errOAAI
errReijers, Irene L. M.; Rawson, Robert, V; Colebatch, Andrew J.; Rozeman, Elisa A.; Menzies, Alex M.; van Akkooi, Alexander C. J.; Shannon, Kerwin F.; Wouters, Michel W.; Saw, Robyn P. M.; van Houdt, Winan J.; Zuur, Charlotte L.; Nieweg, Omgo E.; Ch'ng, Sydney; Klop, W. Martin C.; Spillane, Andrew J.; Long, Georgina, V; Scolyer, Richard A.; van de Wiel, Bart A.; Blank, Christian U.
errShare
errSave
Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage IIIB-D melanoma patients (pts) stratified according to the interferon-gamma signature (IFN-γ sign): The DONIMI study
err2021-09-01
err6
errOAAI
errBlank, C. U.; Reijers, I. L. M.; Versluis, J. M.; Menzies, A. M.; Dimitriadis, P.; Wouters, M. W.; Saw, R. P. M.; Klop, W. M. C.; Pennington, T. E.; Bosch, L. J. W.; Cornelissen, S.; Grijpink-Ongering, L. G.; Gregorio, M. J. C.; Lopez-Yurda, M.; Rawson, R. V.; Spillane, A. J.; De Wiel, B. A. Van; Scolyer, R. A.; Van Akkooi, A. C. J.; Long, G. V.
errShare
errSave
Health-related quality of life in melanoma patients treated with neoadjuvant nivolumab and domatinostat: Preliminary results
err2021-09-01
err0
errOAAI
errVan den Heuvel, N. M. J.; Reijers, I. L. M.; Versluis, J. M.; Menzies, A. M.; Kieffer, J. M.; Kapsali, N.; Wouters, M. W. J. M.; Saw, R. P. M.; Klop, W. M. C.; Pennington, T. E.; Gregorio, M. J. C.; Colebatch, A. J.; Spillane, A. J.; van de Wiel, B. A.; Scolyer, R. A.; van Akkooi, A. C. J.; van de Poll-Franse, L. V.; Long, G. V.; Blank, C. U.; Boekhout, A. H.
errShare
errSave
Clinical models to predict response in mucosal melanoma (MM) patients (pts) treated with anti-PD-1 (PD1) or combined with ipilimumab (PD1+IPI)
err2021-09-01
err0
errOAAI
errDimitriou, F.; Namikawa, K.; Teterycz, P.; Reijers, I. L. M.; Buchbinder, E.; Soon, J.; Zimmer, L.; Mooradian, M.; Vitale, M. G.; Armstrong, E.; Johnson, D.; Guo, J.; Lebbe, C.; Robert, C.; Mandala, M.; Bhave, P.; Farid, M.; Kaehler, K. C.; Lo, S.; Long, G. V.
errShare
errSave
Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab: Week 60 update of the PRADO trial
err2021-09-01
err0
errOAAI
errVan Den Heuvel, N. M. J.; Reijers, I. L. M.; Versluis, J. M.; Rozeman, E. A.; Saw, R. P. M.; Blommers, K. H.; Jozwiak, K.; Suijkerbuijk, K.; Kapiteijn, E.; Van der Veldt, A. A. M.; Hospers, G. A.; Spillane, A. J.; Pennington, T. E.; Wouters, M. W. J. M.; Menzies, A. M.; van Akkooi, A. C. J.; Van De Poll-Franse, L. V.; Long, G. V.; Blank, C. U.; Boekhout, A. H.
errShare
errSave
Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
err2021-07-01
err87
PREAI
errOwen, C. N.; Bai, X.; Quah, T.; Lo, S. N.; Allayous, C.; Callaghan, S.; Martinez-Vila, C.; Wallace, R.; Bhave, P.; Reijers, I. L. M.; Thompson, N.; Vanella, V.; Gerard, C. L.; Aspeslagh, S.; Labianca, A.; Khattak, A.; Mandala, M.; Xu, W.; Neyns, B.; Michielin, O.; Blank, C. U.; Welsh, S. J.; Haydon, A.; Sandhu, S.; Mangana, J.; McQuade, J. L.; Ascierto, P. A.; Zimmer, L.; Johnson, D. B.; Arance, A.; Lorigan, P.; Lebbe, C.; Carlino, M. S.; Sullivan, R. J.; Long, G., V; Menzies, A. M.
errShare
errSave